Skip to content

CBD: all studies

Page 34 of 38: studies 331 to 340 of 375, newest first. Back to the CBD overview

Research

Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans.

Neuropharmacology June 2018 Patrick D. Skosnik, Mihály Hajós, Jose A Cortes-Briones et al.

Cannabis use has been associated with altered sensory gating and neural oscillations. However, it is unclear which constituent in cannabis is responsible for these effects, or whether these are cannabinoid receptor 1 (CB1R) mediated. Therefore, the present study in humans and rats examined whether cannabinoid administration would disrupt sensory gating and evoked oscillations utilizing...

Determination of Acid and Neutral Cannabinoids in Extracts of Different Strains of Cannabis sativa Using GC-FID.

Planta Medica March 2018 Elsayed A Ibrahim, Waseem Gul, Shahbaz W Gul et al.

Cannabis (Cannabis sativa L.) is an annual herbaceous plant that belongs to the family Cannabaceae. Trans-Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) are the two major phytocannabinoids accounting for over 40% of the cannabis plant extracts, depending on the variety. At the University of Mississippi, different strains of C. sativa, with different concentration ratios of CBD and...

Novel treatment options in depression and psychosis

Neuropsychiatric Disease and Treatment March 1, 2018 Eva Češková, Petr Šilhán

Eva Ceskova, Petr Silhan Department of Psychiatry, University Hospital Ostrava, Ostrava, Czech Republic Abstract: In spite of tremendous development in central nervous system research, current treatment is suboptimal, especially in severe mental disorders. In medicine, there are two main methods of improving the health care provided: seeking new treatment procedures and perfecting (optimizing)...

DOI: 10.2147/ndt.s157475 (opens in new tab) Aripiprazole Lurasidone Schizophrenia object-oriented programming Intensive care medicine +1

Do psychoactive drugs have a therapeutic role in compulsivity? Studies on schedule-induced polydipsia.

Psychopharmacology February 2018 Elena Martín-González, Ángeles Prados-Pardo, Santiago Mora et al.

Clinical studies have shown that some psychoactive recreational drugs have therapeutic applications in anxiety, depression, and schizophrenia. However, to date, there are few studies on the therapeutic potential efficacy of recreational drugs in compulsive neuropsychiatric disorders. We explored the therapeutic potential of different psychoactive and psychedelic drugs in a preclinical model of...

DOI: 10.1007/s00213-017-4819-y (opens in new tab) Full text (opens in new tab) Compulsivity Psychedelic drugs Psychoactive drugs Schedule-induced polydipsia

A reliable and validated LC-MS/MS method for the simultaneous quantification of 4 cannabinoids in 40 consumer products.

PLoS One 2018 Qingfang Meng, Beth Buchanan, Jonathan Zuccolo et al.

In the past 50 years, Cannabis sativa (C. sativa) has gone from a substance essentially prohibited worldwide to one that is gaining acceptance both culturally and legally in many countries for medicinal and recreational use. As additional jurisdictions legalize Cannabis products and the variety and complexity of these products surpass the classical dried plant material, appropriate methods for...

Cannabis, cannabinoids, and health

Dialogues in Clinical Neuroscience September 1, 2017 Geneviève Lafaye, Laurent Karila, Lisa Blecha et al.

Cannabis (also known as marijuana) is the most frequently used illicit psychoactive substance in the world. Though it was long considered to be a “soft” drug, studies have proven the harmful psychiatric and addictive effects associated with its use. A number of elements are responsible for the increased complications of cannabis use, including the increase in the potency of cannabis and an...

Can we make cannabis safer?

The Lancet Psychiatry August 2017 Amir Englund, Tom P. Freeman, Robin Murray et al.

Cannabis use and related problems are on the rise globally alongside an increase in the potency of cannabis sold on both black and legal markets. Additionally, there has been a shift towards abandoning prohibition for a less punitive and more permissive legal stance on cannabis, such as decriminalisation and legalisation. It is therefore crucial that we explore new and innovative ways to reduce...

Recommendation to reconsider examining cannabis subtypes together due to opposing effects on brain, cognition and behavior

Neuroscience & Biobehavioral Reviews June 1, 2017 Kristine Rømer Thomsen, M. B. Callesen, S. W. F. Ewing

Cannabis use represents a major public health issue throughout the globe. Yet, we still lack the most fundamental knowledge on long-term effects of cannabis on neural, cognitive, and behavioral function. Part of this stems from how cannabis has been measured historically. To this end, most empirical examinations of cannabis have consolidated all types of cannabis collectively. However, this...

Cannabis in Chinese Medicine: Are Some Traditional Indications Referenced in Ancient Literature Related to Cannabinoids?

Frontiers in Pharmacology March 10, 2017 E. Brand, Zhong-Zhen Zhao

Cannabis sativa L. (Cannabaceae) has a long history of utilization as a fiber and seed crop in China, and its achenes (“seeds”) as well as other plant parts have been recorded in Chinese medical texts for nearly 2000 years. While the primary applications of cannabis in Chinese medicine center around the use of the achenes, ancient indications for the female inflorescence, and other plant parts...

An Introduction to Cannabis

Cannabinoids and the Brain March 1, 2017 Linda A. Parker

Although cannabis has been used throughout human history, the scientific investigation of its effects only began with the isolation of THC in the 1960’s. Once discovered it was another 20 years before the mechanism by which THC produces its psychoactive effects in the brain, the CB1 receptor, was discovered. Cannabis contains over 80 cannabinoid compounds, but THC is the only intoxicating...